Do Insomnia Treatments Improve Daytime Function?

Author:

Watson Nathaniel F.1ORCID,Bertisch Suzanne M.2,Morin Charles M.3,Pelayo Rafael4ORCID,Winkelman John W.56,Zee Phyllis C.7ORCID,Krystal Andrew D.89

Affiliation:

1. Department of Neurology, University of Washington School of Medicine, Seattle, WA 98104, USA

2. Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02130, USA

3. Department of Psychology, Cervo/Brain Research Centre, Laval University, Québec City, QC G1J 2G3, Canada

4. Department of Psychiatry and Behavioral Sciences, Stanford University Sleep Medicine Center, Redwood City, CA 94063, USA

5. Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA

6. Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA

7. Department of Neurology, Center for Circadian and Sleep Medicine, Northwestern University, Evanston, IL 60209, USA

8. Department of Psychiatry, UCSF Weill Institute for Neurosciences, San Francisco, CA 94103, USA

9. Department of Neurology, UCSF Weill Institute for Neurosciences, San Francisco, CA 94103, USA

Abstract

A scientific advisory panel of seven U.S. and Canadian sleep experts performed a clinical appraisal by comparing general medical opinion, assessed via a survey of practicing clinicians, regarding insomnia treatment, with the available scientific evidence. This clinical appraisal focuses on the specific statement, “Treatments for insomnia have uniformly been shown to significantly improve the associated daytime impairment seen with insomnia.” The advisory panel reviewed and discussed the available body of evidence within the published medical literature to determine what discrepancies may exist between the currently published evidence base and general medical opinion. The advisory panels’ evaluation of this statement was also compared with the results of a national survey of primary care physicians, psychiatrists, nurse practitioners, physician assistants, and sleep specialists in the United States. Contrary to general medical opinion, the expert advisory panel concluded that the medical literature did not support the statement. This gap highlights the need to educate the general medical community regarding insomnia treatment efficacy in pursuit of improved treatment outcomes.

Funder

Idorsia Pharmaceuticals Ltd.

LAS Communications, Inc.

Publisher

MDPI AG

Subject

General Medicine

Reference30 articles.

1. A review of lifestyle factors that contribute to important pathways associated with major depression: Diet, sleep and exercise;Lopresti;J. Affect. Disord.,2013

2. Association between Physical Activity, Sedentary Behaviors, Sleep, Diet, and Adiposity among Children and Adolescents in China;Ding;Obes. Facts,2022

3. Centers for Disease Control and Prevention (2022, September 01). Sleep and Sleep Disorders: Data and Statistics, Available online: https://www.cdc.gov/sleep/data_statistics.html.

4. Kushida, C.A. (2013). Reference Module in Neuroscience and Biobehavioral Psychology, Encyclopedia of Sleep, Academic Press.

5. Prevalence of chronic insomnia in adult patients and its correlation with medical comorbidities;Bhaskar;J. Fam. Med. Prim. Care,2016

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3